Press Releases July 29, 2026 04:05 PM

OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference

OrthoPediatrics to Present at Canaccord Genuity 46th Annual Growth Conference

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
KIDS

OrthoPediatrics Corp., specializing exclusively in pediatric orthopedic products, announced that its CEO and COO/CFO will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference. The event aims to highlight company growth and strategies, with an audio webcast available for investors and stakeholders.

OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference
KIDS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Company leadership will engage in a high-profile investor conference presentation, increasing visibility.
  • OrthoPediatrics offers over 90 orthopedic systems targeting pediatric trauma, deformity, scoliosis, and sports medicine.
  • The company has a global presence, distributing products in the U.S. and over 75 countries worldwide.

WARSAW, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference, held in Boston, MA.

Event: Canaccord Genuity 46th Annual Growth Conference
Format: Fireside Chat
Date: Wednesday, August 12, 2026
Time: 9:00 am ET

An audio webcast of the discussion will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be available after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com 
415-937-5406


Risks

  • Uncertainty surrounding market reaction to conference presentation and any guidance shared.
  • Competition in the pediatric orthopedic medical device market could affect growth prospects.
  • Dependence on global healthcare markets means international regulatory or economic changes may impact business.

More from Press Releases

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants Sep 15, 2026 INNSUITES ANNOUNCES 2027 FISCAL FIRST HALF $4M RECORD REVENUES; REVERSE MERGER INTEREST INCREASES Sep 15, 2026 Apollo Provides $585 Million Financing to The Executive Centre Sep 15, 2026 TTM Technologies, Inc. to Exhibit at electronica India 2026 Trade Fair in Bangalore, Showcasing Leading Advanced Interconnect Solutions and Integrated Systems Sep 15, 2026 Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical Sep 15, 2026